Lymphatic filariasis (LF) is a disease not just treatable or controllable; it is a disease that can
be eliminated. Indeed, LF is currently the target of a major global initiative to do just that; a …

The ambitious and exciting Global Programme to Eliminate Lymphatic Filariasis (GPELF) is
largely based on a strategy of mass drug administration (MDA) of repeated rounds of …

Malaria and lymphatic filariasis are two of the most common mosquito-borne parasitic
diseases worldwide which can occur as concomitant human infections while also sharing …

Human African Trypanosomiasis (HAT) transmitted by the tsetse fly continues to be a public
health issue, despite more than a century of research. There are two types of the disease …

We developed and evaluated real-time polymerase chain reaction (PCR) assays for
detecting Wuchereria bancrofti DNA in human blood and in mosquitoes. An assay based on …

Background A dramatic decline in the incidence of malaria due to Plasmodium falciparum
infection in coastal East Africa has recently been reported to be paralleled (or even …

Current population-based schistosomiasis treatment programs are a first step to reducing
the global burden of Schistosoma-related disease; however, they might not dramatically …

Background This study employed various monitoring methods to assess the impact of
repeated rounds of mass drug administration (MDA) on bancroftian filariasis in Papua New …

Measuring transmission of a vector-borne infection is essential to understanding infection
dynamics. When infection prevalence in the vector population is low, transmission is often …

The scientific community recognizes that molecular xenomonitoring (MX) can allow infected
mosquitoes to serve as a proxy for human infection in vector-borne disease surveillance, but …